NEW YORK – Which articles gained the most attention from GenomeWeb's readers last week? Here are the top five:
- Patient Square Capital Agrees to Acquire NanoString Technologies for $220M
- Early IDENTIFY Trial Results Suggest Half of Women With Non-Reportable NIPT Result Have Cancer
- Sequence Variant, CNV Classification Standard Updates Previewed at ACMG Meeting
- Ambry Genetics, Tempus to Offer Paired Germline and Somatic Oncology Testing Services
- NanoString Customers Cautiously Optimistic About Future as Company Declares 'Not Going Away'